Barely Significant
← all excerpts

Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis.

J Chin Med Assoc · 2022 · PMC12755711 · PMID 34759209

Europe PMCDOI
1
hedged sentence
0.0520
closest p · 1.0× alpha
0.0520
boldest claim

The sentences

trend toward significancep = 0.052so close (0.05 < p ≤ 0.1)
Significant improvements in albumin (from 3.2 ± 0.5 to 3.5 ± 0.5 g/dL, p < 0.001), ALT (from 71.5 ± 60.5 to 25.5 ± 11.6 IU/L, p < 0.001), AST (from 92.6 ± 76.9 to 41.9 ± 18.3 IU/L, p < 0.001), total bilirubin (from 2.2 ± 1.2 to 1.8 ± 1.0 mg/dL, p = 0.015), INR (from 1.35 ± 0.3 to 1.25 ± 0.2, p = 0.02), and improvement in PT (from 14.5 ± 3.5 to 13.7 ± 1.9 s, trend toward significance, p = 0.052) were observed after successful DAA therapy.

also in 304 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.